Literature DB >> 30923101

Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia.

Armin Ghobadi1, Christopher A Miller2,3, Tiandao Li3, Michelle O'Laughlin3, Yi-Shan Lee4, Mohga Ali4, Peter Westervelt2, John F DiPersio2, Lukas Wartman2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30923101      PMCID: PMC6669153          DOI: 10.3324/haematol.2019.217794

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Studying the mononuclear phagocyte system in the molecular age.

Authors:  Andrew Chow; Brian D Brown; Miriam Merad
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

2.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

Review 3.  Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Authors:  Jean-François Emile; Oussama Abla; Sylvie Fraitag; Annacarin Horne; Julien Haroche; Jean Donadieu; Luis Requena-Caballero; Michael B Jordan; Omar Abdel-Wahab; Carl E Allen; Frédéric Charlotte; Eli L Diamond; R Maarten Egeler; Alain Fischer; Juana Gil Herrera; Jan-Inge Henter; Filip Janku; Miriam Merad; Jennifer Picarsic; Carlos Rodriguez-Galindo; Barret J Rollins; Abdellatif Tazi; Robert Vassallo; Lawrence M Weiss
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

4.  Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Authors:  Carl E Allen; Liunan Li; Tricia L Peters; Hon-Chiu Eastwood Leung; Alexander Yu; Tsz-Kwong Man; Sivashankarappa Gurusiddappa; Michelle T Phillips; M John Hicks; Amos Gaikwad; Miriam Merad; Kenneth L McClain
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

Review 5.  The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.

Authors:  Julien Haroche; Fleur Cohen-Aubart; Frédéric Charlotte; Philippe Maksud; Philippe A Grenier; Philippe Cluzel; Alexis Mathian; Jean-François Emile; Zahir Amoura
Journal:  Expert Rev Clin Immunol       Date:  2015-07-21       Impact factor: 4.473

6.  Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

Authors:  Beatrice U Mueller; Thomas Pabst; Motomi Osato; Norio Asou; Lisa M Johansen; Mark D Minden; Gerhard Behre; Wolfgang Hiddemann; Yoshiaki Ito; Daniel G Tenen
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

7.  Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

Authors:  Eli L Diamond; Benjamin H Durham; Julien Haroche; Zhan Yao; Jing Ma; Sameer A Parikh; Zhaoming Wang; John Choi; Eunhee Kim; Fleur Cohen-Aubart; Stanley Chun-Wei Lee; Yijun Gao; Jean-Baptiste Micol; Patrick Campbell; Michael P Walsh; Brooke Sylvester; Igor Dolgalev; Olga Aminova; Adriana Heguy; Paul Zappile; Joy Nakitandwe; Chezi Ganzel; James D Dalton; David W Ellison; Juvianee Estrada-Veras; Mario Lacouture; William A Gahl; Philip J Stephens; Vincent A Miller; Jeffrey S Ross; Siraj M Ali; Samuel R Briggs; Omotayo Fasan; Jared Block; Sebastien Héritier; Jean Donadieu; David B Solit; David M Hyman; José Baselga; Filip Janku; Barry S Taylor; Christopher Y Park; Zahir Amoura; Ahmet Dogan; Jean-Francois Emile; Neal Rosen; Tanja A Gruber; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2015-11-13       Impact factor: 39.397

8.  The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.

Authors:  Pedro A Pérez-Mancera; Alistair G Rust; Louise van der Weyden; Glen Kristiansen; Allen Li; Aaron L Sarver; Kevin A T Silverstein; Robert Grützmann; Daniela Aust; Petra Rümmele; Thomas Knösel; Colin Herd; Derek L Stemple; Ross Kettleborough; Jacqueline A Brosnan; Ang Li; Richard Morgan; Spencer Knight; Jun Yu; Shane Stegeman; Lara S Collier; Jelle J ten Hoeve; Jeroen de Ridder; Alison P Klein; Michael Goggins; Ralph H Hruban; David K Chang; Andrew V Biankin; Sean M Grimmond; Lodewyk F A Wessels; Stephen A Wood; Christine A Iacobuzio-Donahue; Christian Pilarsky; David A Largaespada; David J Adams; David A Tuveson
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

9.  BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Authors:  Marie-Luise Berres; Karen Phaik Har Lim; Tricia Peters; Jeremy Price; Hitoshi Takizawa; Hélène Salmon; Juliana Idoyaga; Albert Ruzo; Philip J Lupo; M John Hicks; Albert Shih; Stephen J Simko; Harshal Abhyankar; Rikhia Chakraborty; Marylene Leboeuf; Monique Beltrão; Sérgio A Lira; Kenneth M Heym; Venetia Bigley; Matthew Collin; Markus G Manz; Kenneth McClain; Miriam Merad; Carl E Allen
Journal:  J Exp Med       Date:  2014-03-17       Impact factor: 14.307

10.  Age-related mutations associated with clonal hematopoietic expansion and malignancies.

Authors:  Mingchao Xie; Charles Lu; Jiayin Wang; Michael D McLellan; Kimberly J Johnson; Michael C Wendl; Joshua F McMichael; Heather K Schmidt; Venkata Yellapantula; Christopher A Miller; Bradley A Ozenberger; John S Welch; Daniel C Link; Matthew J Walter; Elaine R Mardis; John F Dipersio; Feng Chen; Richard K Wilson; Timothy J Ley; Li Ding
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

View more
  7 in total

1.  Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation.

Authors:  Pauline Bonnet; François Chasset; Philippe Moguelet; Noémie Abisror; Raphaël Itzykson; Jean-David Bouaziz; Pierre Hirsch; Annick Barbaud; Julien Haroche; Arsène Mekinian; Zofia Hélias-Rodzewicz; Emmanuelle Clappier; Pierre Fenaux; Olivier Fain; Abdellatif Tazi; Jean-François Emile
Journal:  Haematologica       Date:  2019-06-20       Impact factor: 9.941

2.  Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease.

Authors:  Jithma P Abeykoon; Terra L Lasho; Surendra Dasari; Karen L Rech; Wasantha K Ranatunga; Michelle K Manske; Alexander Tischer; Aishwarya Ravindran; Jason R Young; William Oliver Tobin; Eoin P Flanagan; Kevin E Nowakowski; Gordon J Ruan; Mithun V Shah; Nabila Nora Bennani; Robert Vassallo; Jay H Ryu; Matthew J Koster; Caroline J Davidge-Pitts; Mrinal M Patnaik; Xiaosheng Wu; Thomas E Witzig; Gaurav Goyal; Ronald S Go
Journal:  Am J Hematol       Date:  2022-01-03       Impact factor: 13.265

3.  Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report.

Authors:  Andreas Mavrogenis; Vasiliki Pappa; Periklis G Foukas; Sotirios G Papageorgiou; Aspasia Divane; Maria Roumelioti; Christine Kottaridi; Anthi Bouchla; Alexandros Georgakopoulos; Fotini Ieremiadou; Aggeliki Daraki; Efthymia Bazani; Thomas P Thomopoulos; Sofia Chatziioannou; Panayiotis Panayiotidis; Ioannis G Panayiotides
Journal:  Onco Targets Ther       Date:  2020-11-16       Impact factor: 4.147

Review 4.  Histiocytosis.

Authors:  Jean-François Emile; Fleur Cohen-Aubart; Matthew Collin; Sylvie Fraitag; Ahmed Idbaih; Omar Abdel-Wahab; Barrett J Rollins; Jean Donadieu; Julien Haroche
Journal:  Lancet       Date:  2021-04-23       Impact factor: 202.731

5.  MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis.

Authors:  Ran Weissman; Eli L Diamond; Julien Haroche; Benjamin H Durham; Fleur Cohen; Justin Buthorn; Zahir Amoura; Jean-François Emile; Roei D Mazor; Noam Shomron; Omar I Abdel-Wahab; Ofer Shpilberg; Oshrat Hershkovitz-Rokah
Journal:  Leukemia       Date:  2021-11-16       Impact factor: 11.528

6.  Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia.

Authors:  Shintaro Kazama; Kazuaki Yokoyama; Toshimitsu Ueki; Hiroko Kazumoto; Hidetoshi Satomi; Masahiko Sumi; Ichiro Ito; Nozomi Yusa; Rika Kasajima; Eigo Shimizu; Rui Yamaguchi; Seiya Imoto; Satoru Miyano; Yukihisa Tanaka; Tamami Denda; Yasunori Ota; Arinobu Tojo; Hikaru Kobayashi
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

7.  Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.

Authors:  Paul G Kemps; Konnie M Hebeda; Steven T Pals; Robert M Verdijk; King H Lam; Annette H Bruggink; Heleen S de Lil; Bart Ruiterkamp; Koen de Heer; Jan Am van Laar; Peter Jm Valk; Pim Mutsaers; Mark-David Levin; Pancras Cw Hogendoorn; Astrid Gs van Halteren
Journal:  J Pathol Clin Res       Date:  2020-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.